| Year |
Citation |
Score |
| 2021 |
Alzhrani RF, Xu H, Moon C, Suggs LJ, Williams RO, Cui Z. Thin-Film Freeze-Drying Is a Viable Method to Convert Vaccines Containing Aluminum Salts from Liquid to Dry Powder. Methods in Molecular Biology (Clifton, N.J.). 2183: 489-498. PMID 32959262 DOI: 10.1007/978-1-0716-0795-4_27 |
0.332 |
|
| 2020 |
Trementozzi AN, Hufnagel S, Xu H, Hanafy MS, Rosero Castro F, Smyth HDC, Cui Z, Stachowiak JC. Gap Junction Liposomes for Efficient Delivery of Chemotherapeutics to Solid Tumors. Acs Biomaterials Science & Engineering. 6: 4851-4857. PMID 33455217 DOI: 10.1021/Acsbiomaterials.0C01047 |
0.374 |
|
| 2020 |
Xu H, Alzhrani RF, Warnken ZN, Thakkar SG, Zeng M, Smyth HDC, Williams Iii RO, Cui Z. Immunogenicity of antigen adjuvanted with AS04 and its deposition in the upper respiratory tract after intranasal administration. Molecular Pharmaceutics. PMID 32787271 DOI: 10.1021/Acs.Molpharmaceut.0C00372 |
0.457 |
|
| 2020 |
Wang J, Peng Y, Xu H, Cui Z, Williams RO. The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation. Aaps Pharmscitech. 21: 225. PMID 32761294 DOI: 10.1208/S12249-020-01744-7 |
0.365 |
|
| 2020 |
Valdes SA, Alzhrani RF, Lansakara-P DSP, Cui Z. Effect of a Solid Lipid Nanoparticle Formulation on the Bioavailability of 4-(N)-Docosahexaenoyl 2', 2'-Difluorodeoxycytidine After Oral Administration. Aaps Pharmscitech. 21: 77. PMID 31970527 DOI: 10.1208/S12249-020-1617-3 |
0.341 |
|
| 2019 |
O'Mary HL, Hanafy MS, Aldayel AM, Valdes SA, Alzhrani RF, Hufnagel S, Koleng JJ, Cui Z. Effect of the Ratio of Betamethasone to TNF-α siRNA Coencapsulated in Solid Lipid Nanoparticles on the Acute Proinflammatory Activity of the Nanoparticles. Molecular Pharmaceutics. PMID 31525980 DOI: 10.1021/Acs.Molpharmaceut.9B00629 |
0.371 |
|
| 2019 |
Valdes SA, Alzhrani RF, Rodriguez A, Lansakara-P DSP, Thakkar SG, Cui Z. A solid lipid nanoparticle formulation of 4-(N)-docosahexaenoyl 2', 2'-difluorodeoxycytidine with increased solubility, stability, and antitumor activity. International Journal of Pharmaceutics. 118609. PMID 31415878 DOI: 10.1016/J.Ijpharm.2019.118609 |
0.441 |
|
| 2019 |
Li X, Valdes SA, Alzhrani RF, Hufnagel S, Hursting S, Cui Z. Zoledronic Acid-Containing Nanoparticles With Minimum Premature Release Show Enhanced Activity Against Extraskeletal Tumor. Acs Applied Materials & Interfaces. PMID 30689348 DOI: 10.1021/Acsami.8B16588 |
0.438 |
|
| 2019 |
Coleman MF, Liu KA, Tang X, Fabela S, Lashinger LM, Cui Z, Hursting SD. Abstract 1090: β-Hydroxy-β-Methylbutyrate supplementation preserves muscle mass and reduces tumor growth in obese mice Cancer Research. 79: 1090-1090. DOI: 10.1158/1538-7445.Am2019-1090 |
0.393 |
|
| 2018 |
Thakkar SG, Warnken Z, Alzhrani R, Valdes SA, Aldayel AM, Xu H, Williams RO, Cui Z. Intranasal immunization with aluminum salt-adjuvanted dry powder vaccine. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30339906 DOI: 10.1016/J.Jconrel.2018.10.020 |
0.403 |
|
| 2018 |
Aldayel AM, O'Mary HL, Valdes SA, Li X, Thakkar SG, Mustafa BE, Cui Z. Lipid nanoparticles with minimum burst release of TNF-α siRNA show strong activity against rheumatoid arthritis unresponive to methotrexate. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 29859232 DOI: 10.1016/J.Jconrel.2018.05.035 |
0.351 |
|
| 2018 |
Chen Z, Zheng Y, Shi Y, Cui Z. Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles. International Journal of Nanomedicine. 13: 319-336. PMID 29391792 DOI: 10.2147/Ijn.S149196 |
0.384 |
|
| 2018 |
Thakkar SG, Xu H, Li X, Cui Z. Uric acid and the vaccine adjuvant activity of aluminum (oxy)hydroxide nanoparticles. Journal of Drug Targeting. 1-23. PMID 29334279 DOI: 10.1080/1061186X.2018.1428808 |
0.427 |
|
| 2017 |
Wang C, Zheng Y, Sand Oval MA, Valdes SA, Chen Z, Lansakara-P DS, Du M, Shi Y, Cui Z. Oral 4-(N)-stearoyl gemcitabine nanoparticles inhibit tumor growth in mouse models. Oncotarget. 8: 89876-89886. PMID 29163795 DOI: 10.18632/Oncotarget.21264 |
0.449 |
|
| 2017 |
Bahamondez-Canas TF, Cui Z. Intranasal Immunization with Dry Powder Vaccines. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 29122735 DOI: 10.1016/J.Ejpb.2017.11.001 |
0.366 |
|
| 2017 |
Xu H, Ruwona TB, Thakkar SG, Chen Y, Zeng M, Cui Z. Nasal aluminum (oxy)hydroxide enables adsorbed antigens to induce specific systemic and mucosal immune responses. Human Vaccines & Immunotherapeutics. 0. PMID 28933668 DOI: 10.1080/21645515.2017.1365995 |
0.448 |
|
| 2017 |
Li X, Hufnagel S, Xu H, Valdes SA, Thakkar SG, Cui Z, Celio H. Aluminum (oxy)hydroxide nanosticks synthesized in bicontinuous reverse microemulsion have potent vaccine adjuvant activity. Acs Applied Materials & Interfaces. PMID 28621928 DOI: 10.1021/Acsami.7B03965 |
0.417 |
|
| 2017 |
O'Mary HL, Aldayel AM, Valdes SA, Naguib YW, Li X, Salvady K, Cui Z. Acid-sensitive sheddable PEGylated, mannose-modified nanoparticles increase the delivery of betamethasone to chronic inflammation sites in a mouse model. Molecular Pharmaceutics. PMID 28463518 DOI: 10.1021/Acs.Molpharmaceut.7B00024 |
0.363 |
|
| 2017 |
Xu H, Li X, Cui Z. Toward understanding the mechanism underlying the strong adjuvant activity of aluminum salt nanoparticles. Ruwona TB, Xu H, Li X, Taylor AN, Shi Y, Cui Z. Vaccine 2016;34:3059-67. Vaccine. 35: 1102-1103. PMID 28183431 DOI: 10.1016/J.Vaccine.2016.12.047 |
0.372 |
|
| 2017 |
Thakkar SG, Ruwona TB, Williams RO, Cui Z. The Immunogenicity of Thin-Film Freeze-Dried, Aluminum Salt-adjuvanted Vaccine When Exposed to Different Temperatures. Human Vaccines & Immunotherapeutics. 0. PMID 28051903 DOI: 10.1080/21645515.2016.1259042 |
0.351 |
|
| 2017 |
Thakkar SG, Cui Z. Methods to Prepare Aluminum Salt-Adjuvanted Vaccines. Methods in Molecular Biology (Clifton, N.J.). 1494: 181-199. PMID 27718194 DOI: 10.1007/978-1-4939-6445-1_13 |
0.346 |
|
| 2016 |
Wu SC, Yi PF, Guo X, Zhang LY, Xu DX, Fu YX, Cui ZQ, Shen HQ, Wei XB, Fu BD. Cinobufagin enhances the protective efficacy of formalin-inactivated Salmonella typhimurium vaccine through Th1 immune response. Microbial Pathogenesis. PMID 27574776 DOI: 10.1016/j.micpath.2016.08.036 |
0.338 |
|
| 2016 |
Aldayel AM, Naguib YW, O'Mary HL, Li X, Niu M, Ruwona TB, Cui Z. Acid-Sensitive Sheddable PEGylated PLGA Nanoparticles Increase the Delivery of TNF-α siRNA in Chronic Inflammation Sites. Molecular Therapy. Nucleic Acids. 5: e340. PMID 27434685 DOI: 10.1038/Mtna.2016.39 |
0.371 |
|
| 2016 |
Ruwona TB, Xu H, Li X, Taylor A, Shi YC, Cui Z. Toward understanding the mechanism underlying the strong adjuvant activity of aluminum salt nanoparticles. Vaccine. PMID 27155490 DOI: 10.1016/J.Vaccine.2016.04.081 |
0.451 |
|
| 2016 |
Niu M, Valdes S, Naguib YW, Hursting SD, Cui Z. Tumor-Associated Macrophage-Mediated Targeted Therapy of Triple-Negative Breast Cancer. Molecular Pharmaceutics. PMID 27074028 DOI: 10.1021/Acs.Molpharmaceut.5B00987 |
0.403 |
|
| 2016 |
Ruwona TB, Xu H, Li J, Diaz-Arévalo D, Kumar A, Zeng M, Cui Z. Induction of protective neutralizing antibody responses against botulinum neurotoxin serotype C using plasmid carried by PLGA nanoparticles. Human Vaccines & Immunotherapeutics. 0. PMID 26837242 DOI: 10.1080/21645515.2015.1122147 |
0.451 |
|
| 2016 |
Naguib YW, Lansakara-P D, Lashinger LM, Rodriguez BL, Valdes S, Niu M, Aldayel AM, Peng L, Hursting SD, Cui Z. Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2', 2'-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity. Neoplasia (New York, N.Y.). 18: 33-48. PMID 26806350 DOI: 10.1016/J.Neo.2015.11.012 |
0.353 |
|
| 2016 |
Ebelt ND, Taveres CDJ, Xie X, Naguib YW, Jose J, Ruwona TB, Devkota AK, Park J, Kaoud TS, Anslyn EV, Chang JT, Cui Z, Bartholomeusz C, Dalby KN. Abstract 3774: KD06 is a novel anti-cancer drug that causes cell death in triple-negative breast cancer cell lines and tumor xenografts Cancer Research. 76: 3774-3774. DOI: 10.1158/1538-7445.Am2016-3774 |
0.316 |
|
| 2015 |
Zheng YQ, Naguib YW, Dong Y, Shi YC, Bou S, Cui Z. Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy. Expert Review of Vaccines. 14: 1255-75. PMID 26268434 DOI: 10.1586/14760584.2015.1068124 |
0.364 |
|
| 2015 |
Li X, Thakkar SG, Ruwona TB, Williams RO, Cui Z. A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution. Journal of Controlled Release : Official Journal of the Controlled Release Society. 204: 38-50. PMID 25735896 DOI: 10.1016/J.Jconrel.2015.02.035 |
0.345 |
|
| 2015 |
Aldayel AM, Niu M, Cui Z. 168. A Novel TNF-alpha siRNA Formulation for Potential Treatment of Chronic Inflammation Molecular Therapy. 23: S67. DOI: 10.1016/S1525-0016(16)33773-X |
0.301 |
|
| 2015 |
Li X, Thakkar SG, Ruwona TB, Williams RO, Cui Z. Corrigendum to “A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution” [J. Control. Release 204 (2015) 38–50] Journal of Controlled Release. 209: 197. DOI: 10.1016/J.Jconrel.2015.04.030 |
0.337 |
|
| 2014 |
Ruwona TB, Cui Z. Highlights from the latest articles on vaccine development using nanoparticles. Nanomedicine (London, England). 9: 2611-2. PMID 25529565 DOI: 10.2217/Nnm.14.176 |
0.452 |
|
| 2014 |
Niu M, Naguib YW, Aldayel AM, Shi YC, Hursting SD, Hersh MA, Cui Z. Biodistribution and in vivo activities of tumor-associated macrophage-targeting nanoparticles incorporated with doxorubicin. Molecular Pharmaceutics. 11: 4425-36. PMID 25314115 DOI: 10.1021/Mp500565Q |
0.465 |
|
| 2014 |
Naguib YW, Kumar A, Cui Z. The effect of microneedles on the skin permeability and antitumor activity of topical 5-fluorouracil. Acta Pharmaceutica Sinica. B. 4: 94-99. PMID 25313350 DOI: 10.1016/J.Apsb.2013.12.013 |
0.324 |
|
| 2014 |
Naguib YW, Rodriguez BL, Li X, Hursting SD, Williams RO, Cui Z. Solid lipid nanoparticle formulations of docetaxel prepared with high melting point triglycerides: in vitro and in vivo evaluation. Molecular Pharmaceutics. 11: 1239-49. PMID 24621456 DOI: 10.1021/Mp4006968 |
0.388 |
|
| 2014 |
Li X, Aldayel AM, Cui Z. Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles. Journal of Controlled Release : Official Journal of the Controlled Release Society. 173: 148-57. PMID 24188959 DOI: 10.1016/J.Jconrel.2013.10.032 |
0.503 |
|
| 2013 |
Zhu S, Niu M, O'Mary H, Cui Z. Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles. Molecular Pharmaceutics. 10: 3525-30. PMID 23901887 DOI: 10.1021/Mp400216R |
0.449 |
|
| 2013 |
Rodriguez BL, Blando JM, Lansakara-P DSP, Kiguchi Y, Digiovanni J, Cui Z. Antitumor activity of tumor-targeted RNA replicase-based plasmid that expresses interleukin-2 in a murine melanoma model Molecular Pharmaceutics. 10: 2404-2415. PMID 23641783 DOI: 10.1021/Mp400033M |
0.34 |
|
| 2013 |
Wonganan P, Lansakara-P DS, Zhu S, Holzer M, Sandoval MA, Warthaka M, Cui Z. Just getting into cells is not enough: mechanisms underlying 4-(N)-stearoyl gemcitabine solid lipid nanoparticle's ability to overcome gemcitabine resistance caused by RRM1 overexpression. Journal of Controlled Release : Official Journal of the Controlled Release Society. 169: 17-27. PMID 23570983 DOI: 10.1016/J.Jconrel.2013.03.033 |
0.359 |
|
| 2013 |
De Angel RE, Blando JM, Hogan MG, Sandoval MA, Lansakara-P DS, Dunlap SM, Hursting SD, Cui Z. Stearoyl gemcitabine nanoparticles overcome obesity-induced cancer cell resistance to gemcitabine in a mouse postmenopausal breast cancer model. Cancer Biology & Therapy. 14: 357-64. PMID 23358472 DOI: 10.4161/Cbt.23623 |
0.365 |
|
| 2013 |
Zhu S, Li X, Lansakara-P DS, Kumar A, Cui Z. A nanoparticle depot formulation of 4-(N)-stearoyl gemcitabine shows a strong anti-tumour activity. The Journal of Pharmacy and Pharmacology. 65: 236-42. PMID 23278691 DOI: 10.1111/J.2042-7158.2012.01599.X |
0.348 |
|
| 2012 |
Kumar A, Wonganan P, Sandoval MA, Li X, Zhu S, Cui Z. Microneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticles. Journal of Controlled Release : Official Journal of the Controlled Release Society. 163: 230-9. PMID 22921518 DOI: 10.1016/J.Jconrel.2012.08.011 |
0.449 |
|
| 2012 |
Wonganan P, Chung WG, Zhu S, Kiguchi K, DiGiovanni J, Cui Z. Silencing of ribonucleotide reductase subunit M1 potentiates the antitumor activity of gemcitabine in resistant cancer cells Cancer Biology and Therapy. 13: 908-914. PMID 22785206 DOI: 10.4161/Cbt.20843 |
0.38 |
|
| 2012 |
Xiao G, Li X, Kumar A, Cui Z. Transcutaneous DNA immunization following waxing-based hair depilation elicits both humoral and cellular immune responses. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 82: 212-7. PMID 22771558 DOI: 10.1016/J.Ejpb.2012.06.012 |
0.431 |
|
| 2012 |
Zhu S, Lansakara-P DS, Li X, Cui Z. Lysosomal delivery of a lipophilic gemcitabine prodrug using novel acid-sensitive micelles improved its antitumor activity. Bioconjugate Chemistry. 23: 966-80. PMID 22471294 DOI: 10.1021/Bc2005945 |
0.336 |
|
| 2012 |
Lansakara-P DS, Rodriguez BL, Cui Z. Synthesis and in vitro evaluation of novel lipophilic monophosphorylated gemcitabine derivatives and their nanoparticles. International Journal of Pharmaceutics. 429: 123-34. PMID 22425885 DOI: 10.1016/J.Ijpharm.2012.03.014 |
0.403 |
|
| 2012 |
Rodriguez BL, Li X, Kiguchi K, Digiovanni J, Unger EC, Cui Z. Control of solid tumor growth in mice using EGF receptor-targeted RNA replicase-based plasmid DNA Nanomedicine. 7: 475-491. PMID 22296186 DOI: 10.2217/Nnm.11.112 |
0.408 |
|
| 2012 |
Sloat BR, Kiguchi K, Xiao G, Digiovanni J, Maury W, Cui Z. Transcutaneous DNA immunization following waxing-based hair depilation Journal of Controlled Release. 157: 94-102. PMID 21907253 DOI: 10.1016/J.Jconrel.2011.08.038 |
0.77 |
|
| 2012 |
Sandoval MA, Sloat BR, Lansakara-P. DSP, Kumar A, Rodriguez BL, Kiguchi K, Digiovanni J, Cui Z. EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity Journal of Controlled Release. 157: 287-296. PMID 21871505 DOI: 10.1016/J.Jconrel.2011.08.015 |
0.77 |
|
| 2012 |
Chung WG, Sandoval MA, Sloat BR, Lansakara-P DS, Cui Z. Stearoyl gemcitabine nanoparticles overcome resistance related to the over-expression of ribonucleotide reductase subunit M1. Journal of Controlled Release : Official Journal of the Controlled Release Society. 157: 132-40. PMID 21851843 DOI: 10.1016/J.Jconrel.2011.08.004 |
0.751 |
|
| 2012 |
Lansakara-P. DS, Rodriguez BL, Cui Z. Corrigendum to: Synthesis and in vitro evaluation of novel lipophilic monophosphorylated gemcitabine derivatives and their nanoparticles [Int. J. Pharm. 429 (1–2) (2012) 123–134] International Journal of Pharmaceutics. 438: 336. DOI: 10.1016/J.Ijpharm.2012.08.041 |
0.342 |
|
| 2011 |
Kumar A, Li X, Sandoval MA, Rodriguez BL, Sloat BR, Cui Z. Permeation of antigen protein-conjugated nanoparticles and live bacteria through microneedle-treated mouse skin. International Journal of Nanomedicine. 6: 1253-64. PMID 21753877 DOI: 10.2147/Ijn.S20413 |
0.761 |
|
| 2011 |
Yanasarn N, Sloat BR, Cui Z. Negatively charged liposomes show potent adjuvant activity when simply admixed with protein antigens. Molecular Pharmaceutics. 8: 1174-85. PMID 21615153 DOI: 10.1021/Mp200016D |
0.777 |
|
| 2011 |
Rodriguez BL, Yu Z, Chung WG, Weiss R, Cui Z. Replicase-based plasmid DNA shows anti-tumor activity. Bmc Cancer. 11: 110. PMID 21443770 DOI: 10.1186/1471-2407-11-110 |
0.429 |
|
| 2011 |
Sloat BR, Sandoval MA, Li D, Chung WG, Lansakara-P DSP, Proteau PJ, Kiguchi K, Digiovanni J, Cui Z. In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles International Journal of Pharmaceutics. 409: 278-288. PMID 21371545 DOI: 10.1016/J.Ijpharm.2011.02.037 |
0.794 |
|
| 2011 |
Yu Z, Chung WG, Sloat BR, Löhr CV, Weiss R, Rodriguez BL, Li X, Cui Z. The extent of the uptake of plasmid into the skin determines the immune responses induced by a DNA vaccine applied topically onto the skin. The Journal of Pharmacy and Pharmacology. 63: 199-205. PMID 21235583 DOI: 10.1111/J.2042-7158.2010.01219.X |
0.773 |
|
| 2011 |
Li X, Sloat BR, Yanasarn N, Cui Z. Relationship between the size of nanoparticles and their adjuvant activity: data from a study with an improved experimental design. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 78: 107-16. PMID 21182941 DOI: 10.1016/J.Ejpb.2010.12.017 |
0.779 |
|
| 2011 |
DeAngel R, Sandoval M, Lansakara-P D, Dunlap S, Hursting S, Cui Z. P1-15-02: Nanoparticles Overcome the Decreased Responsiveness of Breast Cancer Cells to a Chemotherapeutic Drug in the Presence of Adipocytes. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P1-15-02 |
0.363 |
|
| 2010 |
Oyewumi MO, Kumar A, Cui Z. Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses. Expert Review of Vaccines. 9: 1095-107. PMID 20822351 DOI: 10.1586/Erv.10.89 |
0.433 |
|
| 2010 |
Sloat BR, Sandoval MA, Cui Z. Towards preserving the immunogenicity of protein antigens carried by nanoparticles while avoiding the cold chain. International Journal of Pharmaceutics. 393: 197-202. PMID 20416366 DOI: 10.1016/J.Ijpharm.2010.04.003 |
0.79 |
|
| 2010 |
Sloat BR, Sandoval MA, Hau AM, He Y, Cui Z. Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticles. Journal of Controlled Release : Official Journal of the Controlled Release Society. 141: 93-100. PMID 19729045 DOI: 10.1016/J.Jconrel.2009.08.023 |
0.802 |
|
| 2009 |
Yanasarn N, Sloat BR, Cui Z. Nanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxel. International Journal of Pharmaceutics. 379: 174-80. PMID 19524029 DOI: 10.1016/J.Ijpharm.2009.06.004 |
0.778 |
|
| 2009 |
Le UM, Kaurin DG, Sloat BR, Yanasarn N, Cui Z. Localized irradiation of tumors prior to synthetic dsRNA therapy enhanced the resultant anti-tumor activity. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 90: 273-9. PMID 19013656 DOI: 10.1016/J.Radonc.2008.10.016 |
0.751 |
|
| 2008 |
Le UM, Shaker DS, Sloat BR, Cui Z. A thermo-sensitive polymeric gel containing a gadolinium (Gd) compound encapsulated into liposomes significantly extended the retention of the Gd in tumors. Drug Development and Industrial Pharmacy. 34: 413-8. PMID 18401783 DOI: 10.1080/03639040701662495 |
0.79 |
|
| 2008 |
Sloat BR, Shaker DS, Le UM, Cui Z. Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens. Fems Immunology and Medical Microbiology. 52: 169-79. PMID 18194342 DOI: 10.1111/J.1574-695X.2007.00347.X |
0.806 |
|
| 2008 |
Le UM, Yanasarn N, Löhr CV, Fischer KA, Cui Z. Tumor chemo-immunotherapy using gemcitabine and a synthetic dsRNA. Cancer Biology & Therapy. 7: 440-7. PMID 18094613 DOI: 10.4161/Cbt.7.3.5423 |
0.784 |
|
| 2007 |
Shaker DS, Sloat BR, Le UM, Löhr CV, Yanasarn N, Fischer KA, Cui Z. Immunization by application of DNA vaccine onto a skin area wherein the hair follicles have been induced into anagen-onset stage. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 2037-43. PMID 17700542 DOI: 10.1038/Sj.Mt.6300286 |
0.764 |
|
| 2007 |
Cui Z, Le UM, Qiu F, Shaker DS. Learning from viruses: the necrotic bodies of tumor cells with intracellular synthetic dsRNA induced strong anti-tumor immune responses. Pharmaceutical Research. 24: 1645-52. PMID 17404807 DOI: 10.1007/S11095-007-9293-5 |
0.754 |
|
| 2006 |
Sloat BR, Cui Z. Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli. Vaccine. 24: 6405-13. PMID 16828937 DOI: 10.1016/J.Vaccine.2006.06.002 |
0.784 |
|
| 2006 |
Cui Z, Sloat BR. Topical immunization onto mouse skin using a microemulsion incorporated with an anthrax protective antigen protein-encoding plasmid. International Journal of Pharmaceutics. 317: 187-91. PMID 16730934 DOI: 10.1016/J.Ijpharm.2006.04.013 |
0.778 |
|
| 2006 |
Sloat BR, Cui Z. Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic-polyribocytidylic acid induced strong mucosal and systemic immunities. Pharmaceutical Research. 23: 1217-26. PMID 16718616 DOI: 10.1007/S11095-006-0206-9 |
0.768 |
|
| 2006 |
Le UM, Cui Z. Biodistribution and tumor-accumulation of gadolinium (Gd) encapsulated in long-circulating liposomes in tumor-bearing mice for potential neutron capture therapy. International Journal of Pharmaceutics. 320: 96-103. PMID 16713149 DOI: 10.1016/J.Ijpharm.2006.04.009 |
0.757 |
|
| 2006 |
Sloat BR, Cui Z. Evaluation of the immune response induced by a nasal anthrax vaccine based on the protective antigen protein in anaesthetized and non-anaesthetized mice. The Journal of Pharmacy and Pharmacology. 58: 439-47. PMID 16597361 DOI: 10.1211/Jpp.58.4.0003 |
0.775 |
|
| 2006 |
Cui Z, Qiu F, Sloat BR. Lecithin-based cationic nanoparticles as a potential DNA delivery system. International Journal of Pharmaceutics. 313: 206-13. PMID 16500053 DOI: 10.1016/J.Ijpharm.2006.01.042 |
0.773 |
|
| 2006 |
Cui Z, Dierling A, Foldvari M. Non-invasive immunization on the skin using DNA vaccine. Current Drug Delivery. 3: 29-35. PMID 16472091 DOI: 10.2174/156720106775197538 |
0.431 |
|
| 2006 |
Le UM, Cui Z. Long-circulating gadolinium-encapsulated liposomes for potential application in tumor neutron capture therapy. International Journal of Pharmaceutics. 312: 105-12. PMID 16457973 DOI: 10.1016/J.Ijpharm.2006.01.002 |
0.753 |
|
| 2006 |
Cui Z, Qiu F. Synthetic double-stranded RNA poly(I:C) as a potent peptide vaccine adjuvant: therapeutic activity against human cervical cancer in a rodent model. Cancer Immunology, Immunotherapy : Cii. 55: 1267-79. PMID 16362407 DOI: 10.1007/s00262-005-0114-6 |
0.36 |
|
| 2006 |
Sloat BR, Cui Z. Strong mucosal and systemic immunities induced by nasal immunization with anthrax protective antigen protein incorporated in liposome-protamine-DNA particles. Pharmaceutical Research. 23: 262-9. PMID 16319999 DOI: 10.1007/S11095-005-9078-7 |
0.765 |
|
| 2006 |
Dierling AM, Sloat BR, Cui Z. Gadolinium incorporated reconstituted chylomicron emulsion for potential application in tumor neutron capture therapy. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 62: 275-81. PMID 16274979 DOI: 10.1016/J.Ejpb.2005.09.004 |
0.761 |
|
| 2005 |
Cui Z, Huang L. Liposome-polycation-DNA (LPD) particle as a carrier and adjuvant for protein-based vaccines: therapeutic effect against cervical cancer. Cancer Immunology, Immunotherapy : Cii. 54: 1180-90. PMID 15846491 DOI: 10.1007/S00262-005-0685-2 |
0.355 |
|
| 2005 |
Cui Z, Han SJ, Vangasseri DP, Huang L. Immunostimulation mechanism of LPD nanoparticle as a vaccine carrier. Molecular Pharmaceutics. 2: 22-8. PMID 15804174 DOI: 10.1021/Mp049907K |
0.352 |
|
| 2005 |
Cui Z, Lockman PR, Atwood CS, Hsu CH, Gupte A, Allen DD, Mumper RJ. Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fã¼R Pharmazeutische Verfahrenstechnik E.V. 59: 263-72. PMID 15661498 DOI: 10.1016/J.Ejpb.2004.07.009 |
0.31 |
|
| 2004 |
Cui Z, Han SJ, Huang L. Coating of mannan on LPD particles containing HPV E7 peptide significantly enhances immunity against HPV-positive tumor. Pharmaceutical Research. 21: 1018-25. PMID 15212168 DOI: 10.1023/B:Pham.0000029292.66792.4F |
0.322 |
|
| 2004 |
Cui Z, Patel J, Tuzova M, Ray P, Phillips R, Woodward JG, Nath A, Mumper RJ. Strong T cell type-1 immune responses to HIV-1 Tat (1-72) protein-coated nanoparticles. Vaccine. 22: 2631-40. PMID 15193389 DOI: 10.1016/J.Vaccine.2003.12.013 |
0.483 |
|
| 2003 |
Hsu CH, Cui Z, Mumper RJ, Jay M. Preparation and characterization of novel coenzyme Q10 nanoparticles engineered from microemulsion precursors. Aaps Pharmscitech. 4: E32. PMID 14621964 DOI: 10.1208/Pt040332 |
0.382 |
|
| 2003 |
Cui Z, Mumper RJ. Microparticles and nanoparticles as delivery systems for DNA vaccines. Critical Reviews in Therapeutic Drug Carrier Systems. 20: 103-37. PMID 14584521 DOI: 10.1615/Critrevtherdrugcarriersyst.V20.I23.10 |
0.452 |
|
| 2003 |
Mumper RJ, Cui Z. Genetic immunization by jet injection of targeted pDNA-coated nanoparticles. Methods (San Diego, Calif.). 31: 255-62. PMID 14511958 DOI: 10.1016/S1046-2023(03)00138-5 |
0.467 |
|
| 2003 |
Cui Z, Hsu CH, Mumper RJ. Physical characterization and macrophage cell uptake of mannan-coated nanoparticles. Drug Development and Industrial Pharmacy. 29: 689-700. PMID 12889787 DOI: 10.1081/Ddc-120021318 |
0.398 |
|
| 2003 |
Cui Z, Baizer L, Mumper RJ. Intradermal immunization with novel plasmid DNA-coated nanoparticles via a needle-free injection device. Journal of Biotechnology. 102: 105-15. PMID 12697387 DOI: 10.1016/S0168-1656(03)00029-4 |
0.467 |
|
| 2003 |
Cui Z, Fountain W, Clark M, Jay M, Mumper RJ. Novel ethanol-in-fluorocarbon microemulsions for topical genetic immunization. Pharmaceutical Research. 20: 16-23. PMID 12608531 DOI: 10.1023/A:1022234305600 |
0.406 |
|
| 2003 |
Cui Z, Mumper RJ. The effect of co-administration of adjuvants with a nanoparticle-based genetic vaccine delivery system on the resulting immune responses. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 55: 11-8. PMID 12551699 DOI: 10.1016/S0939-6411(02)00129-7 |
0.478 |
|
| 2003 |
Mumper RJ, Cui Z, Oyewumi MO. Nanotemplate engineering of cell specific nanoparticles Journal of Dispersion Science and Technology. 24: 569-588. DOI: 10.1081/Dis-120021814 |
0.41 |
|
| 2002 |
Cui Z, Mumper RJ. Plasmid DNA-entrapped nanoparticles engineered from microemulsion precursors: in vitro and in vivo evaluation. Bioconjugate Chemistry. 13: 1319-27. PMID 12440869 DOI: 10.1021/Bc0255586 |
0.307 |
|
| 2002 |
Cui Z, Mumper RJ. Intranasal administration of plasmid DNA-coated nanoparticles results in enhanced immune responses. The Journal of Pharmacy and Pharmacology. 54: 1195-203. PMID 12356273 DOI: 10.1211/002235702320402035 |
0.385 |
|
| 2002 |
Cui Z, Mumper RJ. Bilayer films for mucosal (genetic) immunization via the buccal route in rabbits. Pharmaceutical Research. 19: 947-53. PMID 12180546 DOI: 10.1023/A:1016454003450 |
0.342 |
|
| 2002 |
Cui Z, Mumper RJ. Genetic immunization using nanoparticles engineered from microemulsion precursors. Pharmaceutical Research. 19: 939-46. PMID 12180545 DOI: 10.1023/A:1016402019380 |
0.346 |
|
| 2002 |
Cui Z, Mumper RJ. Coating of cationized protein on engineered nanoparticles results in enhanced immune responses. International Journal of Pharmaceutics. 238: 229-39. PMID 11996826 DOI: 10.1016/S0378-5173(02)00079-0 |
0.346 |
|
| 2002 |
Cui Z, Mumper RJ. Topical immunization using nanoengineered genetic vaccines. Journal of Controlled Release : Official Journal of the Controlled Release Society. 81: 173-84. PMID 11992690 DOI: 10.1016/S0168-3659(02)00051-2 |
0.394 |
|
| 2001 |
Cui Z, Mumper RJ. Chitosan-based nanoparticles for topical genetic immunization Journal of Controlled Release. 75: 409-419. PMID 11489327 DOI: 10.1016/S0168-3659(01)00407-2 |
0.333 |
|
| Show low-probability matches. |